Shurin MR - Search Results

1

Immunological monitoring of the tumor immunoenvironment for clinical trials.

Malyguine AM, Strobl SL, Shurin MR. Malyguine AM, et al. Among authors: shurin mr. Cancer Immunol Immunother. 2012 Feb;61(2):239-247. doi: 10.1007/s00262-011-1148-6. Epub 2011 Nov 12. Cancer Immunol Immunother. 2012. PMID: 22080408 Free PMC article. Review.

2

Dendritic cells presenting tumor antigen.

Shurin MR. Shurin MR. Cancer Immunol Immunother. 1996 Nov;43(3):158-64. doi: 10.1007/s002620050317. Cancer Immunol Immunother. 1996. PMID: 9001569 Review.

3

Interferon regulatory factor 8 mediates tumor-induced inhibition of antigen processing and presentation by dendritic cells.

Tourkova IL, Shurin GV, Ferrone S, Shurin MR. Tourkova IL, et al. Among authors: shurin gv, shurin mr. Cancer Immunol Immunother. 2009 Apr;58(4):567-74. doi: 10.1007/s00262-008-0579-1. Epub 2008 Aug 28. Cancer Immunol Immunother. 2009. PMID: 18751977 Free PMC article.

4

New perspectives in cancer immunotherapy and immunomonitoring.

Umansky V, Malyguine A, Shurin M. Umansky V, et al. Future Oncol. 2009 Sep;5(7):941-4. doi: 10.2217/fon.09.62. Future Oncol. 2009. PMID: 19792962 Review. No abstract available.

5

Cancer immunotherapy and immunomonitoring (CITIM): redefining cancer therapy.

Malyguine A, Umansky V, Shurin MR. Malyguine A, et al. Among authors: shurin mr. J Immunotoxicol. 2009 Dec;6(4):205-8. doi: 10.3109/15476910903120932. J Immunotoxicol. 2009. PMID: 19908938

6

New flow cytometric assays for monitoring cell-mediated cytotoxicity.

Zaritskaya L, Shurin MR, Sayers TJ, Malyguine AM. Zaritskaya L, et al. Among authors: shurin mr. Expert Rev Vaccines. 2010 Jun;9(6):601-16. doi: 10.1586/erv.10.49. Expert Rev Vaccines. 2010. PMID: 20518716 Free PMC article. Review.

7

Genetically modified dendritic cells in cancer immunotherapy: a better tomorrow?

Shurin MR, Gregory M, Morris JC, Malyguine AM. Shurin MR, et al. Expert Opin Biol Ther. 2010 Nov;10(11):1539-53. doi: 10.1517/14712598.2010.526105. Expert Opin Biol Ther. 2010. PMID: 20955111 Review.

8

From cell regulation to patient survival: 2nd Cancer Immunotherapy and Immunomonitoring (CITIM) meeting, Budapest, 2-5 May 2011.

Umansky V, Malyguine A, Kotlan B, Aptsiauri N, Shurin MR. Umansky V, et al. Among authors: shurin mr. Cancer Immunol Immunother. 2012 Feb;61(2):295-301. doi: 10.1007/s00262-011-1115-2. Epub 2011 Sep 28. Cancer Immunol Immunother. 2012. PMID: 21953053 Free PMC article. No abstract available.

9

Conference Scene: Immunotherapy reaches new milestones in cancer eradication.

Kotlan B, Umansky V, Malyguine AM, Marincola FM, Shurin MR. Kotlan B, et al. Among authors: shurin mr. Immunotherapy. 2011 Oct;3(10):1131-7. doi: 10.2217/imt.11.114. Immunotherapy. 2011. PMID: 21995567

10

Regulatory dendritic cells in the tumor immunoenvironment.

Shurin GV, Ouellette CE, Shurin MR. Shurin GV, et al. Among authors: shurin mr. Cancer Immunol Immunother. 2012 Feb;61(2):223-230. doi: 10.1007/s00262-011-1138-8. Epub 2011 Nov 8. Cancer Immunol Immunother. 2012. PMID: 22065047 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

179 results

Search Page